APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sevoflurane Anesthesia

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sevoflurane Anesthesia Industry Growth and Trends Forecast to 2032

27 December 202593 pages

Choose your research edition.

Industry ResearchSevoflurane Anesthesia Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Sevoflurane Anesthesia Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Sevoflurane Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sevoflurane Anesthesia Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Sevoflurane Anesthesia Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Sevoflurane Anesthesia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sevoflurane Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sevoflurane Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sevoflurane Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sevoflurane Anesthesia include Hengrui, Lunan Pharma, Baxter, Viatris, PT Novell Pharmaceutical, Piramal, Maruishi and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sevoflurane Anesthesia market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sevoflurane Anesthesia market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sevoflurane Anesthesia market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sevoflurane Anesthesia.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sevoflurane Anesthesia market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sevoflurane Anesthesia Market by Company

Hengrui

Lunan Pharma

Baxter

Viatris

PT Novell Pharmaceutical

Piramal

Maruishi

AbbVie

Sevoflurane Anesthesia Segment by Type

250ml/Bottle

120ml/Bottle

Other

Sevoflurane Anesthesia Segment by Application

Hospital

Clinics

Other

Sevoflurane Anesthesia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane Anesthesia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane Anesthesia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane Anesthesia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sevoflurane Anesthesia manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sevoflurane Anesthesia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 250ml/Bottle Table 2. Major Company of 120ml/Bottle Table 3. Major Company of Other Table 4. Global Sevoflurane Anesthesia Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Sevoflurane Anesthesia Sales by Type (2021-2026) & (K Units) Table 6. Global Sevoflurane Anesthesia Sales Market Share in Volume by Type (2021-2026) Table 7. Global Sevoflurane Anesthesia Sales by Type (2021-2026) & (US$ Million) Table 8. Global Sevoflurane Anesthesia Sales Market Share in Value by Type (2021-2026) Table 9. Global Sevoflurane Anesthesia Price by Type (2021-2026) & (US$/Unit) Table 10. Global Sevoflurane Anesthesia Sales by Type (2027-2032) & (K Units) Table 11. Global Sevoflurane Anesthesia Sales Market Share in Volume by Type (2027-2032) Table 12. Global Sevoflurane Anesthesia Sales by Type (2027-2032) & (US$ Million) Table 13. Global Sevoflurane Anesthesia Sales Market Share in Value by Type (2027-2032) Table 14. Global Sevoflurane Anesthesia Price by Type (2027-2032) & (US$/Unit) Table 15. North America Sevoflurane Anesthesia Sales by Type (2021-2026) & (K Units) Table 16. North America Sevoflurane Anesthesia Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Sevoflurane Anesthesia Sales by Type (2021-2026) & (K Units) Table 18. Europe Sevoflurane Anesthesia Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Sevoflurane Anesthesia Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Sevoflurane Anesthesia Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Sevoflurane Anesthesia Sales by Type (2021-2026) & (K Units) Table 22. Latin America Sevoflurane Anesthesia Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Sevoflurane Anesthesia Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Sevoflurane Anesthesia Sales by Type (2021-2026) & (US$ Million) Table 25. Sevoflurane Anesthesia Industry Trends Table 26. Sevoflurane Anesthesia Industry Drivers Table 27. Sevoflurane Anesthesia Industry Opportunities and Challenges Table 28. Sevoflurane Anesthesia Industry Restraints Table 29. Global Sevoflurane Anesthesia Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Sevoflurane Anesthesia Revenue Market Share by Company (2021-2026) Table 31. Global Sevoflurane Anesthesia Sales by Company (2021-2026) & (K Units) Table 32. Global Sevoflurane Anesthesia Sales Share by Company (2021-2026) Table 33. Global Sevoflurane Anesthesia Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Sevoflurane Anesthesia Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Sevoflurane Anesthesia Major Company Production Sites and Headquarters Table 36. Global Sevoflurane Anesthesia Company, Product Type & Application Table 37. Global Sevoflurane Anesthesia Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Sevoflurane Anesthesia by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Sevoflurane Anesthesia Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Sevoflurane Anesthesia Sales by Region (2021-2026) & (K Units) Table 42. Global Sevoflurane Anesthesia Sales Market Share in Volume by Region (2021-2026) Table 43. Global Sevoflurane Anesthesia Sales by Region (2021-2026) & (US$ Million) Table 44. Global Sevoflurane Anesthesia Sales Market Share in Value by Region (2021-2026) Table 45. Global Sevoflurane Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Sevoflurane Anesthesia Sales by Region (2027-2032) & (K Units) Table 47. Global Sevoflurane Anesthesia Sales Market Share in Volume by Region (2027-2032) Table 48. Global Sevoflurane Anesthesia Sales by Region (2027-2032) & (US$ Million) Table 49. Global Sevoflurane Anesthesia Sales Market Share in Value by Region (2027-2032) Table 50. Global Sevoflurane Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Sevoflurane Anesthesia Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Sevoflurane Anesthesia Sales by Application (2021-2026) & (K Units) Table 53. Global Sevoflurane Anesthesia Sales Market Share in Volume by Application (2021-2026) Table 54. Global Sevoflurane Anesthesia Sales by Application (2021-2026) & (US$ Million) Table 55. Global Sevoflurane Anesthesia Sales Market Share in Value by Application (2021-2026) Table 56. Global Sevoflurane Anesthesia Price by Application (2021-2026) & (US$/Unit) Table 57. Global Sevoflurane Anesthesia Sales by Application (2027-2032) & (K Units) Table 58. Global Sevoflurane Anesthesia Sales Market Share in Volume by Application (2027-2032) Table 59. Global Sevoflurane Anesthesia Sales by Application (2027-2032) & (US$ Million) Table 60. Global Sevoflurane Anesthesia Sales Market Share in Value by Application (2027-2032) Table 61. Global Sevoflurane Anesthesia Price by Application (2027-2032) & (US$/Unit) Table 62. North America Sevoflurane Anesthesia Sales by Application (2021-2026) & (K Units) Table 63. North America Sevoflurane Anesthesia Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Sevoflurane Anesthesia Sales by Application (2021-2026) & (K Units) Table 65. Europe Sevoflurane Anesthesia Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Sevoflurane Anesthesia Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Sevoflurane Anesthesia Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Sevoflurane Anesthesia Sales by Application (2021-2026) & (K Units) Table 69. Latin America Sevoflurane Anesthesia Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Sevoflurane Anesthesia Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Sevoflurane Anesthesia Sales by Application (2021-2026) & (US$ Million) Table 72. Hengrui Company Information Table 73. Hengrui Business Overview Table 74. Hengrui Sevoflurane Anesthesia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Hengrui Sevoflurane Anesthesia Product Portfolio Table 76. Hengrui Recent Development Table 77. Lunan Pharma Company Information Table 78. Lunan Pharma Business Overview Table 79. Lunan Pharma Sevoflurane Anesthesia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Lunan Pharma Sevoflurane Anesthesia Product Portfolio Table 81. Lunan Pharma Recent Development Table 82. Baxter Company Information Table 83. Baxter Business Overview Table 84. Baxter Sevoflurane Anesthesia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Baxter Sevoflurane Anesthesia Product Portfolio Table 86. Baxter Recent Development Table 87. Viatris Company Information Table 88. Viatris Business Overview Table 89. Viatris Sevoflurane Anesthesia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Viatris Sevoflurane Anesthesia Product Portfolio Table 91. Viatris Recent Development Table 92. PT Novell Pharmaceutical Company Information Table 93. PT Novell Pharmaceutical Business Overview Table 94. PT Novell Pharmaceutical Sevoflurane Anesthesia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. PT Novell Pharmaceutical Sevoflurane Anesthesia Product Portfolio Table 96. PT Novell Pharmaceutical Recent Development Table 97. Piramal Company Information Table 98. Piramal Business Overview Table 99. Piramal Sevoflurane Anesthesia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Piramal Sevoflurane Anesthesia Product Portfolio Table 101. Piramal Recent Development Table 102. Maruishi Company Information Table 103. Maruishi Business Overview Table 104. Maruishi Sevoflurane Anesthesia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Maruishi Sevoflurane Anesthesia Product Portfolio Table 106. Maruishi Recent Development Table 107. AbbVie Company Information Table 108. AbbVie Business Overview Table 109. AbbVie Sevoflurane Anesthesia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. AbbVie Sevoflurane Anesthesia Product Portfolio Table 111. AbbVie Recent Development Table 112. North America Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. North America Sevoflurane Anesthesia Sales by Country (2021-2026) & (K Units) Table 114. North America Sevoflurane Anesthesia Sales Market Share by Country (2021-2026) Table 115. North America Sevoflurane Anesthesia Sales Forecast by Country (2027-2032) & (K Units) Table 116. North America Sevoflurane Anesthesia Sales Market Share Forecast by Country (2027-2032) Table 117. North America Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Sevoflurane Anesthesia Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Sevoflurane Anesthesia Market Share by Country (2021-2026) Table 120. North America Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Sevoflurane Anesthesia Market Share Forecast by Country (2027-2032) Table 122. Europe Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Europe Sevoflurane Anesthesia Sales by Country (2021-2026) & (K Units) Table 124. Europe Sevoflurane Anesthesia Sales Market Share by Country (2021-2026) Table 125. Europe Sevoflurane Anesthesia Sales Forecast by Country (2027-2032) & (K Units) Table 126. Europe Sevoflurane Anesthesia Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Sevoflurane Anesthesia Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Sevoflurane Anesthesia Market Share by Country (2021-2026) Table 130. Europe Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Sevoflurane Anesthesia Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Sevoflurane Anesthesia Sales by Country (2021-2026) & (K Units) Table 134. Asia-Pacific Sevoflurane Anesthesia Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Sevoflurane Anesthesia Sales Forecast by Country (2027-2032) & (K Units) Table 136. Asia-Pacific Sevoflurane Anesthesia Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Sevoflurane Anesthesia Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Sevoflurane Anesthesia Market Share by Country (2021-2026) Table 140. Asia-Pacific Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Sevoflurane Anesthesia Market Share Forecast by Country (2027-2032) Table 142. Latin America Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Latin America Sevoflurane Anesthesia Sales by Country (2021-2026) & (K Units) Table 144. Latin America Sevoflurane Anesthesia Sales Market Share by Country (2021-2026) Table 145. Latin America Sevoflurane Anesthesia Sales Forecast by Country (2027-2032) & (K Units) Table 146. Latin America Sevoflurane Anesthesia Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Sevoflurane Anesthesia Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Sevoflurane Anesthesia Market Share by Country (2021-2026) Table 150. Latin America Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Sevoflurane Anesthesia Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Sevoflurane Anesthesia Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Sevoflurane Anesthesia Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Sevoflurane Anesthesia Sales Forecast by Country (2027-2032) & (K Units) Table 156. Middle East and Africa Sevoflurane Anesthesia Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Sevoflurane Anesthesia Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Sevoflurane Anesthesia Market Share by Country (2021-2026) Table 160. Middle East and Africa Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Sevoflurane Anesthesia Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Sevoflurane Anesthesia Distributors List Table 165. Sevoflurane Anesthesia Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Sevoflurane Anesthesia Image Figure 2. Global Sevoflurane Anesthesia Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sevoflurane Anesthesia Market Size (2021-2032) & (US$ Million) Figure 4. Global Sevoflurane Anesthesia Sales (2021-2032) & (K Units) Figure 5. 250ml/Bottle Image Figure 6. Global 250ml/Bottle Sales YoY Growth (2021-2032) & (K Units) Figure 7. 120ml/Bottle Image Figure 8. Global 120ml/Bottle Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Sevoflurane Anesthesia Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Sevoflurane Anesthesia Market Share by Type 2025 VS 2032 Figure 13. North America Sevoflurane Anesthesia Sales Market Share in Volume by Type in 2025 Figure 14. North America Sevoflurane Anesthesia Sales Market Share in Value by Type in 2025 Figure 15. Europe Sevoflurane Anesthesia Sales Market Share in Volume by Type in 2025 Figure 16. Europe Sevoflurane Anesthesia Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Sevoflurane Anesthesia Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Sevoflurane Anesthesia Sales Market Share in Value by Type in 2025 Figure 19. Latin America Sevoflurane Anesthesia Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Sevoflurane Anesthesia Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Sevoflurane Anesthesia Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Sevoflurane Anesthesia Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Sevoflurane Anesthesia Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Sevoflurane Anesthesia Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Sevoflurane Anesthesia Market Share by Application 2025 VS 2032 Figure 33. North America Sevoflurane Anesthesia Sales Market Share in Volume by Application in 2025 Figure 34. North America Sevoflurane Anesthesia Sales Market Share in Value by Application in 2025 Figure 35. Europe Sevoflurane Anesthesia Sales Market Share in Volume by Application in 2025 Figure 36. Europe Sevoflurane Anesthesia Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Sevoflurane Anesthesia Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Sevoflurane Anesthesia Sales Market Share in Value by Application in 2025 Figure 39. Latin America Sevoflurane Anesthesia Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Sevoflurane Anesthesia Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Sevoflurane Anesthesia Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Sevoflurane Anesthesia Sales Market Share in Value by Application in 2025 Figure 43. North America Sevoflurane Anesthesia Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Sevoflurane Anesthesia Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Sevoflurane Anesthesia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Sevoflurane Anesthesia Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sevoflurane Anesthesia Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Sevoflurane Anesthesia Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Sevoflurane Anesthesia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Sevoflurane Anesthesia Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sevoflurane Anesthesia Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Sevoflurane Anesthesia Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Sevoflurane Anesthesia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Sevoflurane Anesthesia Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sevoflurane Anesthesia Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Sevoflurane Anesthesia Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Sevoflurane Anesthesia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Sevoflurane Anesthesia Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sevoflurane Anesthesia Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Sevoflurane Anesthesia Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Sevoflurane Anesthesia Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Sevoflurane Anesthesia Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Sevoflurane Anesthesia Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Sevoflurane Anesthesia Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Hengrui
  • Lunan Pharma
  • Baxter
  • Viatris
  • PT Novell Pharmaceutical
  • Piramal
  • Maruishi
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sevoflurane Anesthesia Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sevoflurane Anesthesia Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sevoflurane Anesthesia Market by Type
  6. 1.3.1 250ml/Bottle
  7. 1.3.2 120ml/Bottle
  8. 1.3.3 Other
  9. 1.4 Global Sevoflurane Anesthesia Market Size by Type
  10. 1.4.1 Global Sevoflurane Anesthesia Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Sevoflurane Anesthesia Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Sevoflurane Anesthesia Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Sevoflurane Anesthesia Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Sevoflurane Anesthesia Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Sevoflurane Anesthesia Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Sevoflurane Anesthesia Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Sevoflurane Anesthesia Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sevoflurane Anesthesia Industry Trends
  2. 2.2 Sevoflurane Anesthesia Industry Drivers
  3. 2.3 Sevoflurane Anesthesia Industry Opportunities and Challenges
  4. 2.4 Sevoflurane Anesthesia Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sevoflurane Anesthesia Revenue (2021-2026)
  2. 3.2 Global Top Players by Sevoflurane Anesthesia Sales (2021-2026)
  3. 3.3 Global Top Players by Sevoflurane Anesthesia Price (2021-2026)
  4. 3.4 Global Sevoflurane Anesthesia Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sevoflurane Anesthesia Major Company Production Sites & Headquarters
  6. 3.6 Global Sevoflurane Anesthesia Company, Product Type & Application
  7. 3.7 Global Sevoflurane Anesthesia Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sevoflurane Anesthesia Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sevoflurane Anesthesia Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sevoflurane Anesthesia Tier 1, Tier 2, and Tier 3
4 Sevoflurane Anesthesia Regional Status and Outlook
  1. 4.1 Global Sevoflurane Anesthesia Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sevoflurane Anesthesia Historic Market Size by Region
  3. 4.2.1 Global Sevoflurane Anesthesia Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sevoflurane Anesthesia Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sevoflurane Anesthesia Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sevoflurane Anesthesia Forecasted Market Size by Region
  7. 4.3.1 Global Sevoflurane Anesthesia Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sevoflurane Anesthesia Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sevoflurane Anesthesia Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sevoflurane Anesthesia by Application
  1. 5.1 Sevoflurane Anesthesia Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Sevoflurane Anesthesia Market Size by Application
  6. 5.2.1 Global Sevoflurane Anesthesia Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Sevoflurane Anesthesia Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Sevoflurane Anesthesia Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Sevoflurane Anesthesia Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Sevoflurane Anesthesia Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Sevoflurane Anesthesia Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Sevoflurane Anesthesia Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Sevoflurane Anesthesia Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hengrui
  2. 6.1.1 Hengrui Company Information
  3. 6.1.2 Hengrui Business Overview
  4. 6.1.3 Hengrui Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hengrui Sevoflurane Anesthesia Product Portfolio
  6. 6.1.5 Hengrui Recent Developments
  7. 6.2 Lunan Pharma
  8. 6.2.1 Lunan Pharma Company Information
  9. 6.2.2 Lunan Pharma Business Overview
  10. 6.2.3 Lunan Pharma Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lunan Pharma Sevoflurane Anesthesia Product Portfolio
  12. 6.2.5 Lunan Pharma Recent Developments
  13. 6.3 Baxter
  14. 6.3.1 Baxter Company Information
  15. 6.3.2 Baxter Business Overview
  16. 6.3.3 Baxter Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter Sevoflurane Anesthesia Product Portfolio
  18. 6.3.5 Baxter Recent Developments
  19. 6.4 Viatris
  20. 6.4.1 Viatris Company Information
  21. 6.4.2 Viatris Business Overview
  22. 6.4.3 Viatris Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Viatris Sevoflurane Anesthesia Product Portfolio
  24. 6.4.5 Viatris Recent Developments
  25. 6.5 PT Novell Pharmaceutical
  26. 6.5.1 PT Novell Pharmaceutical Company Information
  27. 6.5.2 PT Novell Pharmaceutical Business Overview
  28. 6.5.3 PT Novell Pharmaceutical Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 PT Novell Pharmaceutical Sevoflurane Anesthesia Product Portfolio
  30. 6.5.5 PT Novell Pharmaceutical Recent Developments
  31. 6.6 Piramal
  32. 6.6.1 Piramal Company Information
  33. 6.6.2 Piramal Business Overview
  34. 6.6.3 Piramal Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Piramal Sevoflurane Anesthesia Product Portfolio
  36. 6.6.5 Piramal Recent Developments
  37. 6.7 Maruishi
  38. 6.7.1 Maruishi Company Information
  39. 6.7.2 Maruishi Business Overview
  40. 6.7.3 Maruishi Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Maruishi Sevoflurane Anesthesia Product Portfolio
  42. 6.7.5 Maruishi Recent Developments
  43. 6.8 AbbVie
  44. 6.8.1 AbbVie Company Information
  45. 6.8.2 AbbVie Business Overview
  46. 6.8.3 AbbVie Sevoflurane Anesthesia Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AbbVie Sevoflurane Anesthesia Product Portfolio
  48. 6.8.5 AbbVie Recent Developments
7 North America by Country
  1. 7.1 North America Sevoflurane Anesthesia Sales by Country
  2. 7.1.1 North America Sevoflurane Anesthesia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sevoflurane Anesthesia Sales by Country (2021-2026)
  4. 7.1.3 North America Sevoflurane Anesthesia Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sevoflurane Anesthesia Market Size by Country
  6. 7.2.1 North America Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sevoflurane Anesthesia Market Size by Country (2021-2026)
  8. 7.2.3 North America Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sevoflurane Anesthesia Sales by Country
  2. 8.1.1 Europe Sevoflurane Anesthesia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sevoflurane Anesthesia Sales by Country (2021-2026)
  4. 8.1.3 Europe Sevoflurane Anesthesia Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sevoflurane Anesthesia Market Size by Country
  6. 8.2.1 Europe Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sevoflurane Anesthesia Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sevoflurane Anesthesia Sales by Country
  2. 9.1.1 Asia-Pacific Sevoflurane Anesthesia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sevoflurane Anesthesia Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sevoflurane Anesthesia Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sevoflurane Anesthesia Market Size by Country
  6. 9.2.1 Asia-Pacific Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sevoflurane Anesthesia Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sevoflurane Anesthesia Sales by Country
  2. 10.1.1 South America Sevoflurane Anesthesia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sevoflurane Anesthesia Sales by Country (2021-2026)
  4. 10.1.3 South America Sevoflurane Anesthesia Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sevoflurane Anesthesia Market Size by Country
  6. 10.2.1 South America Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sevoflurane Anesthesia Market Size by Country (2021-2026)
  8. 10.2.3 South America Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sevoflurane Anesthesia Sales by Country
  2. 11.1.1 Middle East and Africa Sevoflurane Anesthesia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sevoflurane Anesthesia Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sevoflurane Anesthesia Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sevoflurane Anesthesia Market Size by Country
  6. 11.2.1 Middle East and Africa Sevoflurane Anesthesia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sevoflurane Anesthesia Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sevoflurane Anesthesia Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sevoflurane Anesthesia Value Chain Analysis
  2. 12.1.1 Sevoflurane Anesthesia Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sevoflurane Anesthesia Production Mode & Process
  7. 12.2 Sevoflurane Anesthesia Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sevoflurane Anesthesia Distributors
  10. 12.2.3 Sevoflurane Anesthesia Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst